Future of the Biochips Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Biochips Market Size Growth Forecast: What to Expect by 2025?
In recent times, the biochips market has seen swift expansion. The market is projected to increase from a value of $12.62 billion in 2024 to $14.61 billion in 2025, maintaining a compound annual growth rate (CAGR) of 15.7%. The significant growth during the historical period can be linked to the surge in demand for personalized medicine, an increased incidence of chronic diseases, technological advancements, the widened scope of applications in drug discovery, heightened investments in research and development, and favourable regulatory environments.

How Will the Biochips Market Size Evolve and Grow by 2029?
Predictions suggest a swift expansion of the biochips market in the forthcoming years with it projected to reach a staggering $25.78 billion by 2029, accelerating at a compound annual growth rate (CAGR) of 15.2%. The expansion throughout the forecast period is consequent to factors such as the surge in adoption for point-of-care diagnostics, growth of applications in drug development, escalating demand in personalized medicine and advancements in the field of microfluidics technology. Infrastructural developments like the rising investments in research and development, amplified collaborations between biotechnological firms and academic institutions, as well as budding opportunities in agricultural biotechnology also contribute significantly. The trends that will dominate the forecast period would include technological advancements in microfluidics, focus on creating biochips for liquid biopsy applications, increasing demand for multiplex assays for simultaneous multiple analyte detection, incorporation of artificial intelligence for data interpretation, and the advent of novel biochip platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biochips-global-market-report

What Drivers Are Propelling the Growth of Biochips Market Forward?
The biochips market is expected to see a significant growth propelled by the escalating adoption of personalized medicines. Personalized medicine adopts a tailored approach to medical treatment, based on individual factors like genetics or lifestyle, to enhance effectiveness and reduce side effects. The rising demand for this type of medicine is spurred by its potential to offer more efficient therapies, progress in genomics, the growing intricacy of diseases, and regulatory endorsement. Biochips contribute to personalized medicine by facilitating accurate and custom-made treatment strategies based on a person's genetic makeup. For example, in February 2024, the Personalized Medicine Coalition, a non-profit body based in the U.S., highlighted that the FDA gave the green light to 16 innovative personalized therapies in 2023 for patients diagnosed with rare illnesses, a significant increase from just six in 2022. Therefore, the escalating adoption of personalized medicines is stimulating growth in the biochips market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp

What Are the Key Trends Driving Biochips Market Growth?
Leading businesses in the biochips market are focusing on creating state-of-the-art technologies, such as organ-on-a-chip platforms, with the intention of transforming the methods of drug discovery and development. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic human organ functions and attributes on a smaller scale. As an example, in April 2024, Boston Micro Fabrication (BMF), an American nanotechnology research firm, initiated BMF Biotechnology Inc. This entity concentrates on biochips, also recognized as organ-on-a-chip platforms, with the purpose of encouraging the in vitro growth of tissues on a large scale. This pioneering advancement aids in the faster development of new drugs and beauty products by presenting a platform for testing and experimentation beyond the human body.

What Are the Key Segments in the Biochips Market?
The biochips market covered in this report is segmented -

1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
2) By Technology: Microarrays, Microfluidics
3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users

Subsegments:
1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays
2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays
3) By Lab-On-Chip: Microfluidic Devices, Biosensors
4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays
5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15737&type=smp

Who Are the Key Players Shaping the Biochips Market's Competitive Landscape?
Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

What Geographic Markets Are Powering Growth in the Biochips Market?
North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15737

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.